Table 1.
Demographic data, baseline characteristics, corticosteroid treatment and lung function (all patients)
| n (female/male) | 245 (194/51) |
| Age (years), median (range) | 57.8 (21 – 85) |
| Corticosteroid treatment | |
| Under ICS treatment, n (%) | 245 (100%) |
| Under OCS treatment, n (%) | 6 (2.5%) |
| Lung function - Degree of severity# (%) | |
| Normal | 1.3 |
| Mild | 23.2 |
| Moderate | 23.2 |
| Moderately severe | 24.3 |
| Severe | 25.0 |
| Very severe | 3.0 |
| FEV1 % predicted, median (range) | 60 (32 – 99) |
| Levels of asthma control* (%) | |
| Controlled | 5.4 |
| Partly controlled | 62.3 |
| Uncontrolled | 32.3 |